In silico models of biomolecular regulation in cancer. annotated with patient-specific gene expression data. can aid in the development of novel personalized cancer therapeutic strategies. Drosophila melanogaster is a well-established animal model that is increasingly being employed to evaluate such preclinical personalized cancer therapies. https://www.diegojavierfares.com/